Revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Reed's, Inc. (REED)
Price—Loading quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.1M | $38.0M | $44.7M | $53.0M | $49.6M | $41.6M | $33.8M | $38.1M | $37.7M | $42.5M | $45.9M | $43.4M | $37.3M | $30.0M | $25.0M | $20.4M |
| Gross profit | $7.0M | $11.4M | $9.7M | $12.1M | $13.6M | $12.8M | $7.9M | $10.7M | $6.9M | $9.2M | $11.6M | $13.0M | $10.8M | $9.1M | $7.4M | $6.1M |
| Gross margin | 20.44% | 29.97% | 21.72% | 22.84% | 27.42% | 30.68% | 23.29% | 28.02% | 18.28% | 21.76% | 25.26% | 29.95% | 28.95% | 30.47% | 29.60% | 29.76% |
| Operating expenses | $22.1M | $19.5M | $19.1M | $26.9M | $29.6M | $21.4M | $22.7M | $18.8M | $18.6M | $12.0M | $14.3M | $12.7M | $11.7M | $9.0M | $7.7M | $6.8M |
| Operating income | −$15.1M | −$8.1M | −$9.4M | −$14.8M | −$16.0M | −$8.6M | −$14.9M | −$8.1M | −$11.7M | −$2.8M | −$2.7M | $276,000 | −$869,000 | $136,000 | −$250,000 | −$724,000 |
| Operating margin | −44.47% | −21.38% | −21.06% | −27.97% | −32.20% | −20.70% | −43.93% | −21.32% | −31.15% | −6.59% | −5.94% | 0.64% | −2.33% | 0.45% | −1.00% | −3.55% |
| EBITDA | −$15.0M | −$8.0M | −$9.3M | −$14.7M | −$15.8M | −$8.5M | −$14.8M | −$8.0M | −$11.2M | −$2.4M | −$1.8M | $1.0M | −$319,000 | $874,000 | $403,000 | −$108,000 |
| EBITDA margin | −44.00% | −21.05% | −20.74% | −27.76% | −31.91% | −20.49% | −43.75% | −21.09% | −29.69% | −5.68% | −3.91% | 2.37% | −0.86% | 2.91% | 1.61% | −0.53% |
| Net income | −$15.8M | −$13.2M | −$15.5M | −$20.1M | −$16.4M | −$10.2M | −$16.1M | −$10.3M | −$18.4M | −$5.0M | −$4.0M | −$754,000 | −$1.5M | −$524,000 | −$941,000 | −$1.3M |
| Net profit margin | −46.51% | −34.65% | −34.72% | −37.81% | −33.07% | −24.46% | −47.64% | −27.10% | −48.72% | −11.79% | −8.62% | −1.74% | −4.08% | −1.75% | −3.76% | −6.43% |
| Basic EPSper basic share | -$1.91 | -$9.81 | -$26.34 | -$54.42 | -$53.94 | -$51.00 | -$138.00 | -$123.00 | -$372.00 | -$111.00 | -$90.00 | -$18.00 | -$36.00 | -$15.00 | -$27.00 | -$42.00 |
| Diluted EPSper diluted share | -$1.91 | -$9.81 | -$26.34 | -$54.42 | -$54.00 | -$51.00 | -$138.00 | -$123.00 | -$372.00 | -$111.00 | -$90.00 | -$18.00 | -$36.00 | — | -$27.00 | -$42.00 |
Owners
Reported shareholders
≈10.29%of listed shares
Zaltzman Leon Michael / Union Square Park Partners, LP / Union Square Park GP, LLC / Union Square Park Capital Management, LLC1.22M shares · Nov 15, 2024
View holders
| Holder | % owned |
|---|---|
Era Regenerative Medicine Ltd / D&D Source of Life Holding Ltd. | —28.21M shares |
Zaltzman Leon Michael / Union Square Park Partners, LP / Union Square Park GP, LLC / Union Square Park Capital Management, LLC | ≈10.29%1.22M shares |
ARMISTICE CAPITAL, LLC | 4.11%486.94K shares |
Bello John | ≈2.18%258.78K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.69%82.23K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.46%54.72K shares |
VANGUARD FIDUCIARY TRUST CO | 0.34%39.91K shares |
BlackRock, Inc. | 0.16%18.87K shares |
MORGAN STANLEY | 0.02%2.51K shares |
Tower Research Capital LLC (TRC) | 0.02%2.41K shares |
UBS Group AG | 0.01%1.44K shares |
COHANE NEAL | ≈<0.01%675 shares |
JONES FINANCIAL COMPANIES LLLP | <0.01%540 shares |
KELLEHER FINANCIAL ADVISORS | <0.01%232 shares |
BARCLAYS PLC | <0.01%58 shares |
GROUP ONE TRADING LLC | <0.01%50 shares |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | <0.01%17 shares |
OSAIC HOLDINGS, INC. | <0.01%16 shares |
Pacific Center for Financial Services | <0.01%16 shares |
FMR LLC | <0.01%3 shares |
Percentages use 11.86M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 4, 2025Form 4 | Era Regenerative Medicine Ltd +1TenPercentOwner | BuyCommon Stock · indirect | 1.08M | — | — | 28.21M |
| Nov 15, 2024Form 4 | Zaltzman Leon Michael +3TenPercentOwner | Sellcommon stock · indirect | 4.5K | $1.11 | $5.0K | 1.22M |
| Nov 14, 2024Form 4 | Zaltzman Leon Michael +3TenPercentOwner | Sellcommon stock · indirect | 6.0K | $1.13 | $6.8K | 1.22M |
| Sep 10, 2024Form 4 | Zaltzman Leon Michael +3TenPercentOwner | Buycommon stock · indirect | 531.2K | $1.50 | $796.8K | 1.23M |
| Sep 10, 2024Form 4 | D&D Source of Life Holding Ltd. +1TenPercentOwner | BuyCommon Stock · indirect | 3.27M | $1.50 | $4.90M | 4.43M |